Skip to main content
AmigoFish

Forever young: the business of longevity drugs

From The Intelligence from The Economist · · 23 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

The success of GLP-1s has prompted biotechs to approach the challenge differently. After years of false starts and disappointing results, longevity drugs (https://www.economist.com/business/2026/11/02/the-quest-for-immortality-has-become-serious-business?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&utm_term=sa.listeners) could be on the horizon. Do immigrants from some countries commit more sex crimes (https://www.economist.com/britain/2026/10/25/do-immigrants-from-some-countries-commit-more-sex-crimes?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&utm_term=sa.listeners)? And the big business of miniatures (https://www.economist.com/culture/2026/10/13/whats-behind-the-big-interest-in-miniatures?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&utm_term=sa.listeners).

Guests and host:

- Shailesh Chitnis, global business writer

- James Fransham, data correspondent

- Sascha Lowdermilk, culture intern

- Ọrẹ Ogunbiyi, co-host of “The Intelligence”

Topics covered:

- Longevity drugs, biotechnology, ageing

- Immigration, sex crime, Britain

- Miniatures, 3D printing, hobbies

Listen to what matters most, from global politics and business to science and technology—subscribe to The Economist (https://subscribenow.economist.com/podcasts-plus).

Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.

Back to The Intelligence from The Economist · Report a problem